Insider trade

CME Group (CME)Director sold ~$224K

Dennis Suskind, Director at CME Group, sold ~$224K of CME Group shares.

~$224K
Approx. value · 748 sh @ $300.00
2,699
Holds after · shares reported
Traded
Feb 6, 2026
Filed
Feb 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 13, 2025CongressDisclosed partial sale of CME — reported range $1,001 - $15,000
  2. Dec 11, 2025Insider · 1 personInsiders: 2 sales (~$6.7M)
  3. Dec 18, 2025CongressDisclosed sale of CME — reported range $1,001 - $15,000
  4. Jan 9, 2026CongressDisclosed purchase of CME — reported range $1,001 - $15,000
  5. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 6, 2026 · this disclosureInsiderDirector sold ~$224K of CME shares in the open market

What came next

  1. Feb 12, 2026Government · Federal Register noticeNotice of an Application of the Chicago Mercantile Exchange Inc. for an Exemption Pursuant to Section 36 of the Securities Exchange Act of 1934 and Request for Comment in Connection With the Opening Price Settlement Requirements of Rule 6h-1(b) Under the Securities Exchange Act of 1934 for Certain Cash-Settled Security Futures
  2. Feb 20, 2026InsiderDirector sold ~$92K of CME shares in the open market
  3. Feb 23, 2026InsiderDirector sold ~$1.3M of CME shares in the open market
  4. Mar 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  5. Mar 6, 2026InsiderDirector sold ~$320K of CME shares in the open market
  6. Mar 12, 2026Insider · Their largest sale since 2013Officer sold ~$1.59M of CME shares in the open market
  7. Mar 17, 2026InsiderOfficer sold ~$1.03M of CME shares in the open market
  8. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  9. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
  10. Apr 22, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  11. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  12. May 15, 2026Insider · 1 personInsiders: 2 sales (~$10.4M)
  13. May 18, 2026Insider · Their largest sale since 2007Officer sold ~$1.75M of CME shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by Dennis Suskind, Director

The full history of Dennis Suskind, Director is on the profile page.

How this filing works

Other disclosures at CME Group

Everything OQRO holds on this company is on its CME page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data